| abstract |
The disclosure provides a phosphatidylinositol 3-kinase (PI3K) inhibitor of formula (I), or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , n, R 3 , R 4 , R 5 and R 6 are as defined herein. These compounds are useful for the treatment of conditions mediated by one or more PI3K isoforms, such as PI3Kδ. The present disclosure further provides pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, as well as to treat a condition mediated by one or more PI3K isoforms such as PI3Kδ. Methods of using these compounds and compositions are provided. |